| CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma B Coiffier, E Lepage, J Brière, R Herbrecht, H Tilly, R Bouabdallah, ... New England Journal of Medicine 346 (4), 235-242, 2002 | 6689 | 2002 |
| Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National … B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ... Clinical Infectious Diseases 46 (12), 1813-21, 2008 | 5921* | 2008 |
| Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis R Herbrecht, DW Denning, TF Patterson, JE Bennett, RE Greene, ... New England Journal of Medicine 347 (6), 408-415, 2002 | 4136* | 2002 |
| Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America TJ Walsh, EJ Anaissie, DW Denning, R Herbrecht, DP Kontoyiannis, ... Clinical Infectious Diseases 46 (3), 327-360, 2008 | 3590 | 2008 |
| Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America TF Patterson, GR Thompson III, DW Denning, JA Fishman, S Hadley, ... Clinical Infectious Diseases 63 (4), e1-e60, 2016 | 2761 | 2016 |
| ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients OA Cornely, M Bassetti, T Calandra, J Garbino, BJ Kullberg, O Lortholary, ... Clinical Microbiology and Infection 18, 19-37, 2012 | 1324 | 2012 |
| Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ... Clinical Microbiology and Infection 24 (Suppl 1), e1-e38, 2018 | 1262 | 2018 |
| International conference for the development of a consensus on the management and prevention of severe candidal infections JE Edwards, GP Bodey, RA Bowden, T Büchner, BE de Pauw, SG Filler, ... Clinical Infectious Diseases 25 (1), 43-59, 1997 | 1114* | 1997 |
| Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis DW Denning, P Ribaud, N Milpied, D Caillot, R Herbrecht, E Thiel, A Haas, ... Clinical Infectious Diseases 34 (5), 563-571, 2002 | 1101 | 2002 |
| Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial TJ Walsh, I Raad, TF Patterson, P Chandrasekar, GR Donowitz, R Graybill, ... Clinical Infectious Diseases 44 (1), 2-12, 2007 | 892 | 2007 |
| Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled … JA Maertens, II Raad, KA Marr, TF Patterson, DP Kontoyiannis, ... The Lancet 387 (10020), 760-769, 2016 | 864 | 2016 |
| Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high–loading dose regimen with standard dosing (AmBiLoad trial) OA Cornely, J Maertens, M Bresnik, R Ebrahimi, AJ Ullmann, E Bouza, ... Clinical Infectious Diseases 44 (10), 1289-1297, 2007 | 833 | 2007 |
| Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma G Hess, R Herbrecht, J Romaguera, G Verhoef, M Crump, C Gisselbrecht, ... Journal of Clinical Oncology 27 (23), 3822-3829, 2009 | 750 | 2009 |
| Candidemia in cancer patients: A prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and … C Viscoli, C Girmenia, A Marinus, L Collette, P Martino, B Vandercam, ... Clinical Infectious Diseases 28 (5), 1071-1079, 1999 | 744 | 1999 |
| Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign RE Greene, HT Schlamm, JW Oestmann, P Stark, C Durand, O Lortholary, ... Clinical Infectious Diseases 44 (3), 373-379, 2007 | 738 | 2007 |
| Posaconazole as salvage therapy for zygomycosis RN Greenberg, K Mullane, JAH Van Burik, I Raad, MJ Abzug, G Anstead, ... Antimicrobial agents and chemotherapy 50 (1), 126-133, 2006 | 667 | 2006 |
| Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis FM Marty, L Ostrosky-Zeichner, OA Cornely, KM Mullane, JR Perfect, ... The Lancet Infectious Diseases 16 (7), 828-837, 2016 | 663 | 2016 |
| ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients F Tissot, S Agrawal, L Pagano, G Petrikkos, AH Groll, A Skiada, ... Haematologica, 2016.152900, 2016 | 658 | 2016 |
| European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3 - 2009 update J Maertens, O Marchetti, R Herbrecht, OA Cornely, U Flückiger, P Frere, ... Bone Marrow Transplantation 46 (5), 709-718, 2011 | 603 | 2011 |
| Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia WU Knauf, T Lissichkov, A Aldaoud, A Liberati, J Loscertales, R Herbrecht, ... Journal of Clinical Oncology 27 (26), 4378-4384, 2009 | 599 | 2009 |
Thomas F PattersonProfessor of Medicine, The University of Texas Health Science Center at San AntonioVerified email at uthscsa.edu
